You Make the Call: Readers' Response

You Make the Call: Readers' Response

How readers responded to this month's You Make the Call question


Disclaimer: ASH does not recommend or endorse any specific tests, physicians, products, procedures, or opinions, and disclaims any representation, warranty, or guaranty as to the same. Reliance on any information provided in this article is solely at your own risk.

Prescription for a patient with type 1 von Willebrand disease who is about to...

Here's how readers responded to a You Make the Call question about a patient with type 1 von Willebrand disease who is about to undergo...

What to prescribe for a patient with newly diagnosed CML who lives outside of...

Here's how readers responded to a You Make the Call question about a patient with newly diagnosed CML who lives outside of the United States. Disclaimer:...

Does this child have both beta and alpha thalassemia trait?

Here's how readers responded to a You Make the Call question about a diagnosis of beta and alpha thalassemia trait. Disclaimer: ASH does not recommend...

How long should a multiple myeloma patient receive lenalidomide maintenance therapy?

Here's how readers responded to a You Make the Call question about lenalidomide maintenance in a patient with multiple myeloma. Disclaimer: ASH does not recommend...

How would you treat a patient with Wilson’s disease and neutropenia?

Here's how readers responded to a You Make the Call question about a patient with Wilson’s disease and neutropenia? Disclaimer: ASH does not recommend or endorse...
Advertisement

Current Issue

June 2018, Volume 4, Issue 7

This issue features a look at gaining oral parity for cancer medications, the unavoidable "bubbles" in which people live and work, and more.